John Schembri - Net Worth and Insider Trading
John Schembri Net Worth
The estimated net worth of John Schembri is at least $102,735 dollars as of 2025-04-12. John Schembri is the See Remarks of Global Blood Therapeutics Inc and owns about 1,500 shares of Global Blood Therapeutics Inc (GBT) stock worth over $102,735. Details can be seen in John Schembri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Schembri has not made any transactions after 2016-01-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Schembri
John Schembri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Schembri owns 1 companies in total, including Global Blood Therapeutics Inc (GBT) .
Click here to see the complete history of John Schembri’s form 4 insider trades.
Insider Ownership Summary of John Schembri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2016-01-07 | See Remarks |
John Schembri Latest Holdings Summary
John Schembri currently owns a total of 1 stock. John Schembri owns 1,500 shares of Global Blood Therapeutics Inc (GBT) as of January 7, 2016, with a value of $102,735.
Latest Holdings of John Schembri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2016-01-07 | 1,500 | 68.49 | 102,735 |
Holding Weightings of John Schembri
John Schembri Form 4 Trading Tracker
According to the SEC Form 4 filings, John Schembri has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the acquisition of 1,500 shares on January 7, 2016, which cost John Schembri around $32,355.
Insider Trading History of John Schembri
- 1
John Schembri Trading Performance
GuruFocus tracks the stock performance after each of John Schembri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Schembri is -14.29%. GuruFocus also compares John Schembri's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Schembri within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Schembri's insider trading performs compared to the benchmark.
Performance of John Schembri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.28 | | | | | |
| Relative Return to S&P 500(%) | -14.04 | | | | | |
John Schembri Ownership Network
Ownership Network List of John Schembri
Ownership Network Relation of John Schembri
John Schembri Owned Company Details
What does Global Blood Therapeutics Inc do?
Who are the key executives at Global Blood Therapeutics Inc?
John Schembri is the See Remarks of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .
Global Blood Therapeutics Inc (GBT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Global Blood Therapeutics Inc Insider Transactions
John Schembri Mailing Address
Above is the net worth, insider trading, and ownership report for John Schembri. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John Schembri's mailing address is: 185 Berry Street Suite 6504 San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
